An ectoparasiticide is an antiparasitic drug used in the treatment of ectoparasitic infestations. Commonly used ectoparasites are Baishenning, sulfur, lindane, DDT, benzyl benzoate, ivermectin and clomiphene.
This report contains market size and forecasts of Ectoparasiticides in global, including the following market information:
- Global Ectoparasiticides Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Ectoparasiticides Market Sales, 2017-2022, 2023-2028, (K Units)
- Global top five Ectoparasiticides companies in 2021 (%)
The global Ectoparasiticides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Permethrin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Ectoparasiticides include Bayer, MSD Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Eli Lilly and Company, Zoetis, Inc., Sanofi, Virbac and Vetoquinol S.A., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Ectoparasiticides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ectoparasiticides Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ectoparasiticides Market Segment Percentages, by Type, 2021 (%)
- Permethrin
- Sulfur
- Lindane
- Dicophane
- Benzyl Benzoate
- Ivermectin
- Crotamiton
- Others
Global Ectoparasiticides Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ectoparasiticides Market Segment Percentages, by Application, 2021 (%)
- Dogs
- Cats
- Cattle
- Pigs
- Sheep and Goats
- Poultry
- Others
Global Ectoparasiticides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Ectoparasiticides Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Ectoparasiticides revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Ectoparasiticides revenues share in global market, 2021 (%)
- Key companies Ectoparasiticides sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Ectoparasiticides sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- MSD Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Eli Lilly and Company
- Zoetis, Inc.
- Sanofi
- Virbac
- Vetoquinol S.A.
- Dechra Pharmaceuticals Plc
- Advance Properties OOD/Huvepharma
